ArticlePloS one2016

Atorvastatin Alleviates Experimental Diabetic Cardiomyopathy by Regulating the GSK-3β-PP2Ac-NF-κB Signaling Axis.

Xiao-Min Ren et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.